CBT
BSX icon

Central Bank & Trust’s Boston Scientific BSX Stock Holding History

Central Bank & Trust’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,026
Closed -$755K – 187
2026
Q1 		$755K Buy
12,026
+1,039
+9% +$83.1K 0.12% 118
2025
Q4 		$1.05M Sell
10,987
-77
-0.7% -$7.55K 0.16% 105
2025
Q3 		$1.08M Buy
11,064
+305
+3% +$31.6K 0.17% 102
2025
Q2 		$1.16M Buy
10,759
+2,517
+31% +$255K 0.19% 99
2025
Q1 		$831K Buy
+8,242
New +$830K 0.14% 113
2019
Q2 		– Sell
-91
Closed -$3K – 261
2019
Q1 		$3K Hold
91
– – ﹤0.01% 261
2018
Q4 		$3K Hold
91
– – ﹤0.01% 259
2018
Q3 		$4K Buy
+91
New +$3.18K ﹤0.01% 255

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Central Bank & Trust's BSX Position: Q2 2026 in Review

Central Bank & Trust sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 12,026 shares — an estimated $755K sold.

Central Bank & Trust first reported a position in BSX in Q3 2018 and held it in 8 quarters. The position peaked at $1.16M in Q2 2025. 241 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Central Bank & Trust reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Central Bank & Trust sold 12,026 Boston Scientific shares in Q2 2026, an estimated $755K.
  • Central Bank & Trust first reported a position in Boston Scientific in Q3 2018 and held it in 8 quarters.
  • Central Bank & Trust's Boston Scientific position peaked at $1.16M in Q2 2025.
  • 241 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Central Bank & Trust's 13F filing for Q2 2026, filed 17 Jul 2026.